Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

DiaMedica Therapeutics (DMAC) Invested Capital (2018 - 2019)

DiaMedica Therapeutics' Invested Capital history spans 2 years, with the latest figure at $9.7 million for Q3 2019.

  • For Q3 2019, Invested Capital rose 136.01% year-over-year to $9.7 million; the TTM value through Sep 2019 reached $9.7 million, up 136.01%, while the annual FY2018 figure was $17.0 million, N/A changed from the prior year.
  • Invested Capital reached $9.7 million in Q3 2019 per DMAC's latest filing, down from $11.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $47.6 million in Q1 2018 to a low of -$42.6 million in Q2 2018.